1-20633892-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_032409.3(PINK1):​c.344A>T​(p.Gln115Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0459 in 1,582,768 control chromosomes in the GnomAD database, including 1,905 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q115H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.035 ( 139 hom., cov: 31)
Exomes 𝑓: 0.047 ( 1766 hom. )

Consequence

PINK1
NM_032409.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.17

Publications

24 publications found
Variant links:
Genes affected
PINK1 (HGNC:14581): (PTEN induced kinase 1) This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008]
MIR6084 (HGNC:50235): (microRNA 6084) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015456975).
BP6
Variant 1-20633892-A-T is Benign according to our data. Variant chr1-20633892-A-T is described in ClinVar as Benign. ClinVar VariationId is 294999.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0533 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PINK1NM_032409.3 linkc.344A>T p.Gln115Leu missense_variant Exon 1 of 8 ENST00000321556.5 NP_115785.1
MIR6084NR_106732.1 linkn.*104A>T downstream_gene_variant
MIR6084unassigned_transcript_48 n.*117A>T downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PINK1ENST00000321556.5 linkc.344A>T p.Gln115Leu missense_variant Exon 1 of 8 1 NM_032409.3 ENSP00000364204.3
MIR6084ENST00000622012.1 linkn.*104A>T downstream_gene_variant 6

Frequencies

GnomAD3 genomes
AF:
0.0354
AC:
5352
AN:
151192
Hom.:
139
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00966
Gnomad AMI
AF:
0.0954
Gnomad AMR
AF:
0.0301
Gnomad ASJ
AF:
0.0349
Gnomad EAS
AF:
0.000197
Gnomad SAS
AF:
0.00583
Gnomad FIN
AF:
0.0447
Gnomad MID
AF:
0.0256
Gnomad NFE
AF:
0.0548
Gnomad OTH
AF:
0.0304
GnomAD2 exomes
AF:
0.0333
AC:
6238
AN:
187552
AF XY:
0.0333
show subpopulations
Gnomad AFR exome
AF:
0.00788
Gnomad AMR exome
AF:
0.0204
Gnomad ASJ exome
AF:
0.0354
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0411
Gnomad NFE exome
AF:
0.0541
Gnomad OTH exome
AF:
0.0390
GnomAD4 exome
AF:
0.0470
AC:
67226
AN:
1431472
Hom.:
1766
Cov.:
36
AF XY:
0.0457
AC XY:
32427
AN XY:
709674
show subpopulations
African (AFR)
AF:
0.00730
AC:
240
AN:
32898
American (AMR)
AF:
0.0218
AC:
887
AN:
40716
Ashkenazi Jewish (ASJ)
AF:
0.0348
AC:
891
AN:
25584
East Asian (EAS)
AF:
0.0000523
AC:
2
AN:
38218
South Asian (SAS)
AF:
0.00704
AC:
579
AN:
82258
European-Finnish (FIN)
AF:
0.0446
AC:
2163
AN:
48516
Middle Eastern (MID)
AF:
0.0109
AC:
58
AN:
5322
European-Non Finnish (NFE)
AF:
0.0548
AC:
60192
AN:
1098794
Other (OTH)
AF:
0.0374
AC:
2214
AN:
59166
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
4120
8240
12361
16481
20601
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2170
4340
6510
8680
10850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0354
AC:
5349
AN:
151296
Hom.:
139
Cov.:
31
AF XY:
0.0339
AC XY:
2507
AN XY:
73926
show subpopulations
African (AFR)
AF:
0.00964
AC:
396
AN:
41094
American (AMR)
AF:
0.0300
AC:
456
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.0349
AC:
121
AN:
3464
East Asian (EAS)
AF:
0.000197
AC:
1
AN:
5072
South Asian (SAS)
AF:
0.00584
AC:
28
AN:
4794
European-Finnish (FIN)
AF:
0.0447
AC:
467
AN:
10450
Middle Eastern (MID)
AF:
0.0274
AC:
8
AN:
292
European-Non Finnish (NFE)
AF:
0.0548
AC:
3722
AN:
67904
Other (OTH)
AF:
0.0301
AC:
63
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
263
527
790
1054
1317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0475
Hom.:
66
Bravo
AF:
0.0326
TwinsUK
AF:
0.0380
AC:
141
ALSPAC
AF:
0.0449
AC:
173
ESP6500AA
AF:
0.00658
AC:
25
ESP6500EA
AF:
0.0450
AC:
360
ExAC
AF:
0.0284
AC:
3311
Asia WGS
AF:
0.00433
AC:
16
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive early-onset Parkinson disease 6 Benign:3
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 11, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
May 14, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.055
T
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.14
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.59
T
MetaRNN
Benign
0.0015
T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
1.3
L
PhyloP100
1.2
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
-0.10
N
REVEL
Benign
0.11
Sift
Benign
0.32
T
Sift4G
Benign
0.20
T
Polyphen
0.12
B
Vest4
0.098
MPC
0.17
ClinPred
0.0044
T
GERP RS
3.9
PromoterAI
-0.0025
Neutral
Varity_R
0.11
gMVP
0.49
Mutation Taster
=84/16
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148871409; hg19: chr1-20960385; API